How Digitization Can Improve Bioprocessing and Make Manufacturing More Robust

Presented by

Charlotte Masy at GSK Vaccines and Ciaran O’Keeffe at MasterControl

About this talk

Presented by Charlotte Masy, Senior Manager in Manufacturing Science and Technology GSK Vaccines and Ciaran O’Keeffe, Director, Business Development & Channel Sales, Asia Pacific Digitalization has been used in a lot of biopharma processes. A lot of data are collected through sensor and process measurement and already used in Machine Learning model. However, regarding Incoming material that may have a huge impact on final drug products not much has been done. Historically this was due to the fact that exchange of data with interfaces was quite difficult. This is changing. Through this Webex we want to show advantages of collecting such critical material data from supplier. We will discuss standard and tips on  how to collect data and interact with supplier regarding incoming material. Concrete examples on how GSK use such tools will be shown. Future trends on how digitalization could be applied to more specific  Incoming material such as Single Use will be developed. Example in the field of extractable and leachable, design or investigation will be explained with expected benefits. This will show you that a new world is opening to all of us with digitalization tools.
Related topics:

More from this channel

Upcoming talks (26)
On-demand talks (368)
Subscribers (36852)
BioPharma Webinars aims to keep its global audience abreast of all developments in the areas of Drug Development, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality webinars, presented by the most respected people, working with companies in Pharmaceutical, Biopharmaceutical, Biologics and Biotech Industry.